David P Bonita
CIK 1572451 · last filed 2026-06-10
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$92.87M
Companies
12
Total Filings
74
Lifetime Open-Market Net
$26.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PRLD | Director | 1,126,126 | $4.49 | $5.06M | $41.00M | 10 | 2026-06-10 |
| IMA | Director | 753,441 | $5.62 | $4.23M | $2.50M | 2 | 2026-04-16 |
| Repare Therapeutics Inc. (RPTX) Delisted | Director | 3,177,041 | $2.65 | $8.42M | $11.29M | 11 | 2024-06-20 |
| Third Harmonic Bio, Inc. (THRD) Delisted | Director | 5,779,071 | $5.38 | $31.09M | $5.10M | 5 | 2024-06-10 |
| ImageneBio, Inc. (IKNA) Delisted | Director | 157,288 | $17.16 | $2.70M | $12.42M | 9 | 2024-06-10 |
| Acutus Medical, Inc. (AFIB) Delisted | Director | 1,698,183 | $0.09 | $152.8K | $22.47M | 6 | 2023-06-15 |
| Tricida, Inc. (TCDA) Delisted | Director | 9,274,110 | $0.11 | $1.00M | -$47.11M | 9 | 2022-11-25 |
| IMRA | Director | 4,199,068 | $17.02 | $71.47M | $35.00M | 5 | 2022-06-03 |
| SIBN | Director | 785,368 | $15.42 | $12.11M | $3.00M | 1 | 2018-10-19 |
| ViewRay, Inc. (VRAY) Delisted | Director | 115,613 | $0.03 | $2.9K | $4.35M | 4 | 2018-04-25 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 941,000 | — | — | -$69.20M | 9 | 2017-12-12 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Director | 13,947 | $0.54 | $7.5K | $5.66M | 2 | 2013-05-24 |
Recent Filings · Page 3 of 8
74 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-10-27 | Third Harmonic Bio, Inc. (THRD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-09-21 | Third Harmonic Bio, Inc. (THRD) Delisted | Mixed | +5,779,071 | $5.10M | EDGAR |
| 2022-06-24 | ImageneBio, Inc. (IKNA) Delisted | Buy (P) | −252,225 | -$1.13M | EDGAR |
| 2022-06-22 | PRLD | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | Acutus Medical, Inc. (AFIB) Delisted | Grant (A) | +8,400 | $0 | EDGAR |
| 2022-06-16 | Tricida, Inc. (TCDA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-13 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-06-03 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2022-05-16 | Repare Therapeutics Inc. (RPTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-12-23 | ImageneBio, Inc. (IKNA) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.